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ABSTRACT
Influenza is an infectious, viral disease caused by the influenza virus. There are four
strains of influenza: Type A, Type B, Type C, Type D. Symptoms can be as mild as a fever,
runny nose, sore throat, headache and cough. These symptoms are very similar to our current
pandemic symptoms of coronavirus SARS-CoV-2, or COVID-19. However, influenza
symptoms can also manifest as severe viral pneumonia, bacterial pneumonia and heart failure.
Influenza surveillance provides present data on the prevalence of influenza within
Nebraska which then allows health professionals to remind the population to get vaccinated and
the importance of social distancing when feeling ill and how to get treated. It is also vital in
providing information regarding the current virulent strain, the target population, and the
effectiveness of the vaccine.
My role in assisting the Department of Health and Human Services (DHHS) prior to the
start of this year’s influenza surveillance season and throughout the beginning was to compile
and analyze previous seasons’ surveillance data and compare to the sentinel providers and
laboratories reporting data, evaluate and enhance current recruiting materials and send to all
health departments within the state, pinpoint areas of surveillance need in the state and recruit
additional sentinel providers, and send out the influenza testing supplies to all sentinel providers
and laboratories. Throughout the beginning and peak influenza season, I evaluated previous
seasons’ influenza reporting and resulting data compared to the 2020-2021 season’s data while
analyzing that data according to patient age and strain type to identify any trends in the positive
results
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CHAPTER 1 – INTRODUCTION
A. Specific Aims
The aim of this project was to maintain or increase the current sentinel sites efficiency in
reporting the patient visits and influenza like illness (ILI) data and to increase the amount of
sentinel providers within the state to allow for more precise influenza data tracking during this
COVID-19 pandemic. This project also compared the previous two seasons’ (2018-2019 and
2019-2020) data with the current 2020-2021 season’s data to identify any trends or differences
between the influenza surveillance seasons. This may indicate interesting variables that can
cause a difference in positive cases; mask wearing, social distancing, and increased hand
hygiene.
B. Significance
In late 2019, SARS-CoV-2 emerged and made headlines. In early 2020, it made its
appearance in the United States. The symptoms of COVID-19 are very similar to influenza
symptoms; fever, cough, fatigue, sore throat, and many others. Influenza is spread in the same
manner as COVID-19 through droplet transmission; droplets spread when one coughs, sneezes
or talks. Now, acquiring influenza data has become more difficult since the country is focusing
on COVID-19 positive patients who could also be influenza positive patients. Providers and
laboratories across the state are more hesitant during this pandemic to be recruited to become an
influenza surveillance sentinel location due to the slight increase in work as the data must be
reported weekly.

3

Efficient surveillance systems around the world are vital to better understand influenza
epidemiology, disease incidence and severity and to develop prevention strategies. Influenza is a
vaccine-preventable disease.
Knowing where influenza is most prevalent and which strain or lineage is infecting the
population through this surveillance data allows recommendations to which area of the state the
vaccines should be administered the most aggressively. In addition, not all strains of influenza
require the same medical treatment. By tracking which strain is most active during the influenza
season, medical professionals can be more aware and educated on which treatment will be most
successful. Influenza infects populations differently. The population data obtained shows health
officials the most affected communities and where an increase in vaccination education and
administration is needed.
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CHAPTER 2 – BACKGROUND
A. Epidemiologic Description of the Health Problem
Influenza is a contagious respiratory virus that infects the nose, throat, and sometimes the
lungs (Centers for Disease Control and Prevention 2019). As mentioned previously, there are
four strains: Influenza A, B, C and D. Influenza types A and B are the viruses that cause
seasonal epidemics known as flu season. Influenza A is the only influenza virus known to cause
global pandemics. Influenza A is further broken down into subtypes based on proteins on the
surface of the virus (Centers for Disease Control and Prevention 2019); influenza A subtype H3
and influenza A subtype H1N1 are also known as seasonal flu. Influenza B is broken down into
lineages based on the differentiation of hemagglutination; Victoria and Yamagata lineages (Biere
et al. 2010). Subtypes of influenza A and lineages of influenza B are included each year in the
season’s influenza vaccines. Influenza C virus infections cause very mild illnesses and are not
known to infect people globally. Influenza D affects cattle and are not known to infect or cause
illness in people.
Sentinel surveillance began in the late 1990s. But the emergence of the 2009 influenza A
(H1N1) strain highlighted the need for more efficient influenza surveillance worldwide. Thus,
the World Health Organization concluded that the world was unprepared to respond to an
influenza pandemic (Ortiz et al. 2009). Researchers began to develop a sentinel surveillance
system that could enhance the epidemiological and laboratory data and increase our preparedness
and prevention.
B. Program Description

5

Nebraska’s influenza surveillance system currently consists of 17 sentinel providers and 18
sentinel laboratories within the state of Nebraska. The purpose of these sentinel providers is to
report the number of influenza like illness patient visits and total number of patient visits by age
group every week into the online CDC database (Influenza Like Illness Network, ILINet). This
database consists of more than 3,000 healthcare providers in all 50 states and reports over 25
million patient visits each year. The sentinel locations also are to submit nasopharyngeal
specimens during each part of the season to the Nebraska Public Health Laboratory for
confirmation. If the specimen is confirmed positive, it will then be sent to the Centers for
Disease Control and Prevention (CDC) for antiviral susceptibility and strain classification.
Because of this partnership with the sentinel providers and laboratories, the Department of
Health and Human Services is able to track where influenza is most prevalent, which virulent
strain is most active, and what population of the state is most affected.
The more data that is obtained throughout the influenza season, the more efficient the
surveillance program. By increasing the amount of sentinel providers and sentinel laboratories,
DHHS is able to track which strain is the most prevalent and provide the CDC with that
information. If influenza activity is confirmed within a community through this tracking, health
professionals are able to treat patients with influenza like illness symptoms within 48 hours of
symptom onset to reduce the severity of their illness.
C. Evaluation Framework
Without the cooperation from the sentinel providers and laboratories, influenza data could
not be obtained. It is vital to the influenza surveillance program that these sentinel locations
submit the data weekly and submit nasopharyngeal specimens to the Nebraska Public Health
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Laboratory for confirmation testing. The data reported weekly into the online database allows
DHHS to evaluate that sentinel location’s reporting data and efficiency. The data can be pulled
for each season and sorted by sentinel location, number of total patient visits each week, number
of those patients with influenza symptoms and the age of the patients.
All the data obtained each season allows health professionals to accurately track influenza
occurrence and prevalence and which strain is the most virulent for that season. Because
influenza viruses undergo constant antigenic change, surveillance is necessary to identify
influenza new virus variants, monitor their health impact in populations, and to provide data
necessary for selection of influenza vaccine components each year. Influenza surveillance
allows public health professionals to identify high-risk patients, determine the effectiveness of
current prevention programs, and refine vaccine recommendations each year (Centers for
Disease Control and Prevention 2017).
D. Hypothesis
I hypothesized that the current 2020-2021 season’s positive results numbers would be lower
than the previous two seasons (2018-2019 and 2019-2020) due to the mask mandate, social
distancing, and increased hand hygiene that has been established around the state all due to the
COVID-19 pandemic.
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CHAPTER 3 – METHODS
A. Evaluation Methods
The process for reporting influence-like-illness (ILI) data is simple for the sentinel providers
and laboratories. All sentinel laboratories and providers from the previous season were
identified and grafted onto a map (See Appendices 1) which allows DHHS a visual aid of the
sentinel provider locations so they could be notified in September via email and asked to
participate this 2020-2021 season. If they choose to opt out, the Department of Health and
Human Services and the health departments used this map to identify areas of need and were
then tasked with recruiting additional sentinel providers or laboratories. Recruitment packets
and a letter of involvement that I enhanced were sent to the health departments across the state to
aid in recruitment (See Appendices 2). Each packet contained information regarding the
importance of influenza surveillance, specimen collection and transport, specimen test ordering
in the Nebraska Public Health NUlirt system (test ordering and result reporting), and instructions
for ILINet reporting. Sentinel providers of any specialty in any type of practice are eligible to be
ILINet providers. However, school health centers and any type of institutional setting such as
nursing homes or prisons are not eligible. Two additional sentinel providers were recruited
toward the peak/end of the season.
Those sentinel locations that chose to report again, were notified and sent 10 influenza
testing kits, free of charge, to utilize for surveillance purposes throughout the season. Each kit
contains one nasopharyngeal swab, one viral transport media container, one biohazard specimen
transport bag, and a recruitment packet.
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These sentinel providers and laboratories are to report once per week the total number of
patients seen for all reasons and the total number of patient visits for ILI (fever ≥ 100◦F and
cough and/or sore throat) by age group (0-4 years, 5-24 years, 25-49 years, 50-64 years, ≥ 65
years). They log onto ILINet online or by fax to a central repository at the CDC (See
Appendices 3). The process to report takes less than 30 minutes to complete to compile and
report their data.
Also, these sentinel laboratories and providers are to submit the provided influenza kits
throughout the season to the Nebraska Public Health Laboratory for confirmation testing, along
with ordering the test in the NUlirt system. During the beginning of the influenza season
(October – December), they are to obtain two or three nasopharyngeal specimens on patients
who exhibit signs and symptoms of ILI regardless of the rapid diagnostic test result performed at
their clinic location. During the peak or middle of the season (January – February), sites should
obtain two or three nasopharyngeal specimens on patients who have tested positive for influenza
by rapid diagnostic testing. Lastly, at the end of the influenza season (March – May), sites need
to obtain two or three nasopharyngeal specimens on patients who exhibit signs and symptoms of
ILI regardless of the rapid diagnostic test. All of the patient specimens must be ordered in the
state reporting system, NUlirt, prior to sending to NPHL. Patient demographics must be entered
as well as the order for the influenza PCR panel, FLUPCR. Such demographic information
includes patient name, date of birth, gender, ethnicity, address, phone number and any symptoms
present. Additional epidemiological questions are included which are sent to the CDC; recent
travel, agriculture exposure and vaccine status.
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The Nebraska Public Health Laboratory will then perform a PCR panel on the submitted
specimens that includes the detections of Influenza, A, B, A-H3, and A-2009 H1. These tests
results are submitted electronically through the state resulting system, NUlirt.
B. Standards and Criteria
The influenza surveillance program is conducted by health professionals who agreed to enroll
in the program. By reporting their data each week and submitting specimens throughout the
season, their program credibility is maintained. This surveillance program is designed to reach
all age groups and all ethnicities and are subject to the patient’s symptoms and rapid influenza
test result.
Based on the needs of the program and data from the previous season, additional sentinel
providers are recruited each season to allow for more precise surveillance throughout the state.
Additional nasopharyngeal kits for surveillance will be sent out if an area of the state is in need.
Health departments are notified prior to and throughout the season regarding the surveillance in
their area.
C. Data Sources and Measurement
Sources of data that were used to track patient visits were conducted internally by the
sentinel providers and laboratories. They reported, by age group, the total patient visits and total
ILI patients every week into the CDC database, ILINet. That data is then downloaded from
ILINet and analyzed by DHHS and myself using Excel. I analyzed the data by age group and by
sentinel location.
The specimens that are submitted to the Nebraska Public Health Laboratory are tracked and
reported using NUlirt. The data is then downloaded from NUlirt into an Excel spreadsheet and
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analyzed by myself. I analyzed the data by age group, time of season, sentinel location and
strain identified by running multiple pivot tables to decipher the data.
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CHAPTER 4 – RESULTS
A. Evaluation Findings
The patient visits reporting data pulled from the ILINet reporting system (See Table 1)
showed that there were 572 ILI patients out of a total of 85,904 patients seen during the current
2020-2021 season. That number of total patients seen was lower than in previous years
reporting. I compared this data to the data from previous years to be able to see if there was a
trend between patient visits in regards to the COVID-19 pandemic. A total of 93,456 patients
were seen with 1,929 seen with ILI during 2019-2020 season. Age 5-24 group had more patients
present than any other age group that season.
There was significantly more patients seen during the 2018-2019 season than any other
season compared. A total of 133,519 patients were seen with 2,529 ILI. Age 5-24 group again
had more patients present than any other age group.

12

Table 1. ILINet Data: Patients Seen per Season
Season

# Total

# Total

Patients

ILI

Seen

Patient

Age 0-4

Age 5-24

Age 25-49

Age 50-64

Age 65
and Up

Seen
2018-2019

133519

2529

546

957

432

326

268

2019-2020

93456

1929

308

743

444

251

183

2020-2021

85904

572

50

122

205

117

78

Data was obtained from NUlirt to analyze the specimens that were sent from the sentinel
laboratories and providers to the Nebraska Public Health Lab for confirmation FLUPCR testing
(See Table 2). Only four specimens have been sent to the Nebraska Public Health Laboratory
and none of them were positive FLUPCR specimens reported as of March 18, 2021 during the
current 2020-2021 season. For the 2019-2020 season, there were a total of 56 specimens
submitted and 36 were confirmed positive by FLUPCR. Of the 36 positive specimens, 25 of
them were of the influenza strain A/H1N1 during the 2019-2020 season. For the 2018-2019
season, there were a total of 36 specimens submitted and of those, 20 were confirmed positive by
FLUPCR. Of the 20 positive specimens, 14 of them were of the influenza strain A, subtype H3
during the 2018-2019 season.
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Table 2. NUlirt Data: FLUPCR Specimen Results by Season
Season

# Specimens

Result

A, Subtype

A/H1N1

B, Victoria

B,

Lineage

Yamagata

H3

Lineage
2018-2019

2019-2020

2020-2021

16

Negative

20

Positive

20

Negative

36

Positive

4

Negative

0

Positive

14

4

2

0

1

25

9

1

0

0

0

0

Data was analyzed from NUlirt to compare the sentinel locations submitting data by time
of each season. Table 3 shows the specimens sent by time of season; Beginning, Peak and End.
The data showed that during the peak of season 2018-2019, influenza A, subtype H3 was the
most prevalent strain with 13 confirmed positive specimens. During the beginning of season
2019-2020, influenza A/H1N1 was the most prevalent strain with 13 confirmed. Influenza
A/H1N1 is the most prevalent strain in Nebraska with 29 confirmed positive specimens in the
last three seasons.
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Table 3. NUlirt Data: FLUPCR Specimen Results by Season

Season

2018-2019

Beginning
Peak
End
Off Season
Beginning
Peak
End
Off Season

2019-2020

2020-2021
Total

Beginning
Peak
End
Off Season

Strain
A,
B,
B,
Subtype
Victoria Yamagata
H3
A/H1N1 Lineage Lineage
Negative
1
4
0
0
6
13
0
0
0
4
0
0
2
0
6
0
0
0
0
0
1
0
0
0
0
0
0
0
19

13
5
1
6
0
0
0
0
29

3
0
0
0
0
0
0
0
5

1
6
0
0
0
0
0
0
7

12
3
5
0
4
0
0
0
40

Table 4 shows the NUlirt confirmed positive specimen submitted data analyzed by age of
patient at time of season. Data showed that there are a higher number of confirmed positive
specimens submitted in the 5-24 age group in all three season with a total of 21 specimens. Age
50-64 group had the least number of overall specimens with 5 submitted.
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Table 4. NUlirt Data: FLUPCR Positive Specimens Submitted by Age by Season
Age

2018-2019

2019-2020

2020-2021

Total

0-4 Years

3

10

0

13

5-24 Years

10

11

0

21

25-49 Years

1

9

0

10

50-64 Years

1

4

0

5

>65 Years

5

2

0

7

Total

20

36

0

As I had hypothesized, the 2020-2021 season showed a decrease in submitted positive
specimen confirmation numbers than previous seasons with only four specimens received for
confirmation testing (See Figure 1). In the 2018-2019 season, 1.4% of the total ILI patients seen
had specimens submitted for confirmation testing with 0.8% of those positive and the 2019-2020
season had 2.9% submission with 1.8% of those positive. This 2020-2021 season, only 0.6% of
ILI patients seen had specimens submitted for confirmation testing and 0% positive. Possible
reasons for the decrease in positive influenza submission cases are the mask mandate that has
been in place since August 2020, social distancing of six feet, more employees and students are
working/schooling from home, increased hand hygiene, and fewer patient visits due to telehealth
availability that has been established around the state all due to the COVID-19 pandemic.
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Figure 1. NUlirt Data: FLUPCR Specimens Submitted 2018-2021

FLUPCR Specimens
3000
2500
2000
1500

1000
500

1.4%
0.8%

2.9%

1.8%

0.6% 0%

0
2018-2019
# ILI Patients Seen

2019-2020
# Specimens Submitted

2020-2021
# Confirmed Positive
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CHAPTER 5 – DISCUSSION
A. Summary
The Department of Health and Human Services influenza surveillance program provides
present data on the prevalence of influenza within Nebraska which also provides information
regarding the current virulent strain, the target population, and the effectiveness of the current
season’s vaccine.
The Nebraska influenza surveillance system currently consists of 17 sentinel providers
and 18 sentinel laboratories within the state of Nebraska who submit weekly data regarding the
total number of patient visits and the total number of those patient visits with influenza like
illness (ILI) by age group. The sentinel locations then submit nasopharyngeal specimens
throughout the season to the Nebraska Public Health Laboratory for confirmation testing. This
2020-2021 influenza season, the sentinel locations reported that only 85,904 total patients were
seen and of those 572 were seen for ILI. In contrast, the 2019-2020 influenza season reported
93,456 total patients seen with 1,929 seen for ILI and the 2018-2019 season reported 133,519
total patients seen with 2,529 of those with ILI.
This 2020-2021 influenza seasons’ data showed that there was a decrease in the number
of total patients seen and total ILI patients seen by our sentinel locations and there have been
zero confirmed positive influenza specimens from the sentinel locations in Nebraska. During the
2019-2020 influenza season, a total of 36 specimens were confirmed positive; 0-4 years of age
group had ten, 5-24 years of age had eleven, 25-49 years of age had nine, 50-64 years of age had
four and age 65 and older had 2. During the 2018-2019 influenza season, a total of 20 specimens
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were confirmed positive; 0-4 years of age group had three, 5-24 years of age had ten, 25-49 and
50-64 years of age both had one, and age 65 and older had five.
In the 2018-2019 season, 1.4% of the total ILI patients seen had specimens submitted for
confirmation testing with 0.8% of those positive and the 2019-2020 season had 2.9% submission
with 1.8% of those positive. This 2020-2021 season, only 0.6% of ILI patients seen had
specimens submitted for confirmation testing and 0% positive.
Due to the COVID-19 pandemic, certain restrictions have been in place since last March;
remote learning for all students, mask mandate, six feet social distancing, remote working for
employees, food and drink establishments were closed or had capacity restrictions, and increased
hand washing practices across the state. All of these criteria appear to have a significant impact
on the amount of positive influenza specimens that the Nebraska Public Health Laboratory
received during this 2020-2021 season as they have only received four specimens for
confirmation testing and none of them were positive.
B. Strengths and Limitations
A strength of this surveillance program is the ease and speediness of reporting the data
into the CDC online database. Health professionals can access this system from anywhere and at
any time to report their patient visits data and it takes less than 30 minutes to complete each
week. Another strength of this program is that the data from the sentinel locations reporting
system and the data from the specimen resulting system can be easily and readily downloaded
into a measurement-ready spreadsheet. This allows DHHS to access the information at any time
to track the progress and efficiency of the season’s surveillance.
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A limitation of this surveillance program is that surveillance is only feasible if the
sentinel locations report their data each week and submit positive specimens for confirmation to
the Nebraska Public Health Laboratory throughout the season. Without their cooperation, proper
surveillance could not be achieved. Another limitation is the access to care for patients. During
the COVID-19 pandemic, many physician offices were not seeing patients. This led to a
decrease in patient visits for ILI symptoms. Some patients were offered a telehealth visit, but
many chose to stay at home and self-quarantine due to the symptom similarity to COVID-19.
These limitations could affect my hypothesis due to the limited amount of data that has been
obtained during the 2020-2021 season . With only four specimens submitted and zero positives
so far, the data cannot be properly analyzed.
C. Recommendations
The influenza surveillance program could be improved by recruiting additional sentinel
locations throughout the state. Engaging the health departments for help can aid in this
recruitment. In September 2020, we did reach out to the health departments and the little
feedback we received showed that most health departments and clinics did not have time to
initiate this program due to the COVID-19 pandemic. Perhaps in future seasons, with the newly
enhanced recruitment packet and the increased need for surveillance during COVID-19, more
sentinel locations will agree to participate in the surveillance program.
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APPLICATION OF PUBLIC HEALTH COMPETENCIES
Foundational Competency #7: Assess population needs, assets and capabilities that affect
communities’ health. Through influenza surveillance, populations’ health are assessed through
the ILI data to track influenza epidemiology.
Environmental and Occupational Health Competency EOHMPH1: Analyze sources of
exposure in the workplace or environment that can cause health risks to humans or degradation
of ecosystems. Influenza surveillance allows public health officials to assess which influenza
strain is infecting the state’s population and to provide better prevention strategies to reduce
exposure.
Environmental and Occupational Health Competency EOHMPH4: Apply genetic and
physiological factors that affect susceptibility to adverse health outcomes following exposure to
environmental and occupational hazards. ILI data that is reported through the sentinel sites is
reported by age group to allow for age-specific tracking. Also, when the sites are ordering the
influenza PCR test in NUlirt for the confirmation specimen, they must provide ethnicity for each
patient. This allows public health officials to track and monitor the effects of influenza on
different minority population.
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